Rhinovirus, airway smooth muscle, and mechanisms of irreversible airflow obstruction
鼻病毒、气道平滑肌和不可逆气流阻塞机制
基本信息
- 批准号:10735460
- 负责人:
- 金额:$ 50.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-09 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:ADRBK1 geneActinsAcuteAdenosine DiphosphateAdultAffectAgonistAirAirway DiseaseArrestin Beta 1AsthmaAttenuatedBronchoconstrictionBronchodilationBronchodilator AgentsCXCR4 ReceptorsCXCR4 geneCalciumCell LineCell physiologyCellsCessation of lifeChildClinicalCoculture TechniquesCoupledCyclic AMPCyclic AMP-Dependent Protein KinasesDataDevelopmentDiseaseEffector CellEpithelial CellsEpitheliumExposure toG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGTP-Binding Protein alpha Subunits, GsGTP-Binding ProteinsHealthHost DefenseHumanImmunityImpairmentInfectionInflammationInflammation MediatorsLiquid substanceLungMMP9 geneMediatingMediatorModelingMolecularMorbidity - disease rateMuscle ContractionMuscle relaxation phaseMyosin Light ChainsNatural regenerationPAR-2 ReceptorPathway interactionsPatientsPhenotypePhosphorylationPhosphotransferasesPre-Clinical ModelProductionProductivityProstaglandinsProteinase-Activated ReceptorsProteinsPublishingRelaxationResearchRhinovirusRhinovirus infectionRho-associated kinaseRoleSignal InductionSignal PathwaySignal TransductionSignaling MoleculeSliceSmall Interfering RNASmooth MuscleSmooth Muscle MyocytesSymptomsSystemTherapeuticTherapeutic UsesUp-RegulationVEGF165ViralViral Respiratory Tract InfectionVirusWorkairway epitheliumairway hyperresponsivenessairway inflammationairway obstructionasthma exacerbationattenuationbeta-2 Adrenergic Receptorsconstrictionexposed human populationgastrointestinal epitheliuminhibitorknock-downloss of functionmortalitynew therapeutic targetnovelphosphoric diester hydrolasepreventreceptorreceptor couplingreceptor functionreduce symptomsrelease factor 3repairedrespiratory smooth muscleresponsetherapeutic targettrefoil factor
项目摘要
Project Abstract:
Rhinoviruses (RV) have been impugned in the development of asthma and are the leading cause of acute
asthma exacerbations. RV exposure evokes inflammation of the airways, but how RV modulates human airway
smooth muscle cell (HASM) function to alter bronchomotor tone is unclear. HASM is the pivotal cell modulating
airway tone, shortening in response to contractile agonist stimulation through increases in intracellular calcium,
through activation of Rho kinase, and through modulation of actin dynamics. We previously showed that RV
exposure evokes AHR in human precision cut lung slices (hPCLS), increases [Ca2+]i in HASM, and increases
agonist-induced phosphorylation of myosin light chain in HASM from human airway epithelial cell (HAEC)/HASM
co-cultures stimulated with RV-C15. We also demonstrate that RVC exposure attenuates β2 agonist-induced
bronchodilation in hPCLS, cAMP production in HASM, and attenuates bronchodilator-induced reversal of HASM
contraction. Our preliminary data shows that TFF3, and other inflammatory mediators, are released from HAEC
and hPCLS following exposure to RVC, and that TFF3 attenuates bronchodilation of human small airways and
production cAMP in HASM in response to bronchodilators. Furthermore, our data demonstrates that inhibition of
TFF3 and putative TFF3 receptors can reverse RV-C15-induced attenuation of bronchodilation. Therefore, we
posit RV-C15 modifies signaling mechanisms modulating bronchomotor tone in HASM through a TFF3-
dependent mechanism, thereby altering responsiveness of the airways to bronchodilators. We also show that
signaling downstream of Gαs-coupled receptors is attenuated in HASM following exposure to RV-C15-
conditioned HAEC media. We propose a central hypothesis that RVC exposure of HAEC attenuates β2
agonist-induced bronchodilation via modulation of Gαs-coupled receptor function via TFF3-dependent
mechanisms. We will utilize HASM cells, air-liquid interface-differentiated HAEC, and hPCLS to examine the
aims of this proposal. In Aim 1, we will determine how RV exposure modulates Gαs-coupled receptor-induced
signaling to attenuate bronchodilator-induced airway/HASM relaxation and how asthma alters these
mechanisms. Aim 2 will examine how RV-C15-induced TFF3 release attenuates agonist-induced
bronchodilation/relaxation of HASM and how asthma alters these mechanisms. Utilizing primary HAEC/HASM
co-cultures and an ex vivo system of human small airways, we will delineate signaling pathway alterations
regulating bronchomotor tone that can be targeted in the treatment of RV-induced exacerbations of asthma to
restore bronchodilator responsiveness.
项目摘要:
鼻病毒(RV)在哮喘的发展中受到质疑,并且是急性哮喘的主要原因。
哮喘恶化。RV暴露引起气道炎症,但RV如何调节人体气道
平滑肌细胞(HASM)改变支气管张力功能尚不清楚。HASM是细胞调节
气道张力,通过细胞内钙的增加响应于收缩激动剂刺激而缩短,
通过激活Rho激酶和通过调节肌动蛋白动力学。我们之前展示了RV
暴露引起人精确切割肺切片(hPCLS)中的AHR,增加HASM中的[Ca 2 +]i,并增加
激动剂诱导的人气道上皮细胞HASM中肌球蛋白轻链磷酸化
用RV-C15刺激的共培养物。我们还证明,RVC暴露减弱β2受体激动剂诱导的
在hPCLS中的支气管扩张,在HASM中的cAMP产生,并减弱支气管扩张剂诱导的HASM逆转
收缩。我们的初步数据表明,TFF 3和其他炎症介质,从HAEC释放,
和hPCLS,并且TFF 3减弱人小气道的支气管扩张,
HASM对支气管扩张剂的反应产生cAMP。此外,我们的数据表明,抑制
TFF 3和推定的TFF 3受体可以逆转RV-C15诱导的支气管扩张衰减。所以我们
HPV-C15通过TFF 3 - 1调节HASM中支气管张力的信号传导机制。
依赖性机制,从而改变气道对支气管扩张剂的反应性。我们也证明了
暴露于RV-C15后,HASM中Gα s偶联受体下游的信号转导减弱。
条件HAEC培养基。我们提出了一个中心假设,即HAEC的RVC暴露减弱了β2
激动剂通过TFF 3依赖性调节Gα s偶联受体功能诱导支气管扩张
机制等我们将利用HASM细胞、气-液界面分化的HAEC和hPCLS来检测HASM细胞的增殖。
这一提议的目的。在目标1中,我们将确定RV暴露如何调节Gα s偶联受体诱导的
减弱支气管哮喘诱导的气道/HASM松弛的信号传导以及哮喘如何改变这些
机制等目的2将检查RV-C15诱导的TFF 3释放如何减弱激动剂诱导的TFF 3释放。
HASM的支气管扩张/松弛以及哮喘如何改变这些机制。利用初级HAEC/HASM
共培养和人类小气道的离体系统,我们将描绘信号通路的改变
调节支气管张力,可靶向治疗RV诱导的哮喘恶化,
恢复支气管扩张剂的反应性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cynthia Koziol-White其他文献
Cynthia Koziol-White的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
- 批准号:
22KJ2613 - 财政年份:2023
- 资助金额:
$ 50.06万 - 项目类别:
Grant-in-Aid for JSPS Fellows
The structural basis of plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
342887 - 财政年份:2016
- 资助金额:
$ 50.06万 - 项目类别:
Operating Grants
The structural basis for plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
278338 - 财政年份:2013
- 资助金额:
$ 50.06万 - 项目类别:
Operating Grants
Cytoplasmic Actins in Maintenance of Muscle Mitochondria
细胞质肌动蛋白在维持肌肉线粒体中的作用
- 批准号:
8505938 - 财政年份:2012
- 资助金额:
$ 50.06万 - 项目类别:
Differential Expression of the Diverse Plant Actins
多种植物肌动蛋白的差异表达
- 批准号:
7931495 - 财政年份:2009
- 资助金额:
$ 50.06万 - 项目类别:
Studies on how actins and microtubules are coordinated and its relevancy.
研究肌动蛋白和微管如何协调及其相关性。
- 批准号:
19390048 - 财政年份:2007
- 资助金额:
$ 50.06万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Interaction of myosin with monomeric actins
肌球蛋白与单体肌动蛋白的相互作用
- 批准号:
5311554 - 财政年份:2001
- 资助金额:
$ 50.06万 - 项目类别:
Priority Programmes
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6316669 - 财政年份:2000
- 资助金额:
$ 50.06万 - 项目类别: